Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care
Language English Country Czech Republic Media print-electronic
Document type Journal Article, Practice Guideline
PubMed
23733084
DOI
10.5507/bp.2013.039
Knihovny.cz E-resources
- MeSH
- Pulmonary Disease, Chronic Obstructive classification diagnosis therapy MeSH
- Consensus MeSH
- Humans MeSH
- Patient-Centered Care MeSH
- Patient Care Planning MeSH
- Pulmonary Medicine MeSH
- Societies, Medical MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Practice Guideline MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: COPD is a global concern. Currently, several sets of guidelines, statements and strategies to managing COPD exist around the world. METHODS: The Czech Pneumological and Phthisiological Society (CPPS) has commissioned an Expert group to draft recommended guidelines for the management of stable COPD. Subsequent revisions were further discussed at the National Consensus Conference (NCC). Reviewers' comments contributed to the establishment of the document's final version. DIAGNOSIS: The hallmark of the novel approach to COPD is the integrated evaluation of the patient's lung functions, symptoms, exacerbations and identifications of clinical phenotype(s). The CPPS defines 6 clinically relevant phenotypes: frequent exacerbator, COPD-asthma overlap, COPD-bronchiectasis overlap, emphysematic phenotype, bronchitic phenotype and pulmonary cachexia phenotype. TREATMENT: Treatment recommendations can be divided into four steps. 1(st) step = Risk exposure elimination: reduction of smoking and environmental tobacco smoke (ETS), decrease of home and occupational exposure risks. 2(nd) step = Standard treatment: inhaled bronchodilators, regular physical activity, pulmonary rehabilitation, education, inhalation training, comorbidity treatment, vaccination. 3(rd) step = Phenotype-specific therapy: PDE4i, ICS+LABA, LVRS, BVR, AAT augmentation, physiotherapy, mucolytic, ABT. 4(th) step = Care for respiratory insufficiency and terminal COPD: LTOT, lung transplantation, high intensity-NIV and palliative care. CONCLUSION: Optimal treatment of COPD patients requires an individualised, multidisciplinary approach to the patient's symptoms, clinical phenotypes, needs and wishes. The new Czech COPD guideline reflects and covers these requirements.
References provided by Crossref.org
Inhaled therapies in patients with moderate COPD in clinical practice: current thinking
Chronic obstructive pulmonary disease guidelines in Europe: a look into the future
Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study
Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
Diagnosing COPD: advances in training and practice - a systematic review
A review of national guidelines for management of COPD in Europe
Czech multicenter research database of severe COPD